⌘K
Loading ticker…
As of 2026-08-21, Tempest Therapeutics, Inc. Common Stock (TPST) has a 3-month relative strength percentile of 8 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 30. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 8.4%, relative volume 0.44×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
TPST is in a stage 4 downtrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -0.5% / -41.8%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
TPST is held by 2 ETFs as of Apr 2026. Top owner: DCOR at 0.00% weight, $8K notional.
Held by 4 ETFs · $392K across latest filings · largest weight 0.00% (DCOR).
Top 2 by value, from SEC N-PORT-P filings dated Apr 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| DCOR | 0.00% | $8K | — |
| DFACDimensional U.S. Core Equity 2 ETF | 0.00% | $213 | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TPST Jan avg: 39.59% median: 41.34% win: 75% σ: 49.56% n: 4 2022-04-12 → 2026-07-31 | TPST Feb avg: -10.35% median: -11.55% win: 0% σ: 5.91% n: 4 2022-04-12 → 2026-07-31 | TPST Mar avg: 0.08% median: -1.71% win: 50% σ: 25.21% n: 4 2022-04-12 → 2026-07-31 | TPST Apr avg: -4.60% median: -8.62% win: 40% σ: 17.48% n: 5 2022-04-12 → 2026-07-31 | TPST May avg: -18.36% median: -20.22% win: 0% σ: 8.90% n: 5 2022-04-12 → 2026-07-31 | TPST Jun avg: -17.91% median: -25.35% win: 20% σ: 19.00% n: 5 2022-04-12 → 2026-07-31 | TPST Jul avg: -12.89% median: -18.72% win: 20% σ: 12.95% n: 5 2022-04-12 → 2026-07-31 | TPST Aug avg: -7.11% median: -10.56% win: 50% σ: 36.35% n: 4 2022-04-12 → 2026-07-31 (current) | TPST Sep avg: -12.66% median: -7.91% win: 50% σ: 23.82% n: 4 2022-04-12 → 2026-07-31 | TPST Oct avg: 303.97% median: 2.67% win: 50% σ: 627.71% n: 4 2022-04-12 → 2026-07-31 | TPST Nov avg: -23.16% median: -13.94% win: 25% σ: 31.41% n: 4 2022-04-12 → 2026-07-31 | TPST Dec avg: -6.33% median: -11.23% win: 25% σ: 22.46% n: 4 2022-04-12 → 2026-07-31 |